Project Grant R01EY037701
- Federal Grant Award Summary The National Eye Institute (NEI) awarded $1,149,778 to the Regents of the University of Minnesota under the Vision Research program (CFDA 93.867) beginning September 1, 2025, and extending through June 30, 2029. This Project Grant supports the creation of the Mental Imagery Database (MID), a comprehensive neuroimaging resource that will collect high-resolution 7-Tesla functional magnetic resonance imaging (fMRI) data capturing brain activity as human subjects generate...
- Federal Grant Award Summary The University of Maryland, Baltimore received a $571,206 Project Grant award from the National Eye Institute (NEI) under the Vision Research program (CFDA 93.867), effective May 1, 2026 through March 31, 2030. This award funds the development, refinement, and validation of sensitive and robust adaptive optics-optical coherence tomography (AO-OCT) biomarkers for glaucoma detection and progression monitoring. The project addresses a critical clinical gap by enabling...
- Federal Project Grant Award Summary Northwestern University received a $1.62 million Project Grant from the National Eye Institute (NEI) under the Vision Research program (CFDA 93.867), with an award date of September 1, 2025, and completion date of August 31, 2028. The grant funds research to develop computational models and digital twin technology for the anterior eye to improve understanding of aqueous humor outflow (AHO) dynamics in glaucoma patients. The project utilizes robotic optical...
- Federal Project Grant Award Summary The National Eye Institute (NEI), under the Vision Research program (CFDA 93.867), awarded a $733,137 Project Grant to the University of California, Los Angeles on September 15, 2025, with a completion date of March 31, 2030. This award funds research investigating how genetic variation influences disease progression and therapeutic response in age-related macular degeneration (AMD), a leading cause of vision loss in older adults. The project integrates...
- Federal Grant Award Summary The National Eye Institute (NEI) awarded a $421,136 Project Grant to the University of Maryland, College Park, effective August 1, 2025, through July 31, 2027, under the Vision Research program (CFDA 93.867). This award supports research into advanced wavefront shaping techniques designed to enable high-resolution fundus imaging in patients with ocular opacities—conditions affecting the cornea and lens that currently prevent effective posterior segment eye...
- Federal Project Grant Award Summary The National Eye Institute (NEI), under the Vision Research program (CFDA 93.867), awarded $875,918 to Oregon Health & Science University to develop, evaluate, and validate large language models (LLMs) for extracting clinical data on amblyopia treatment, adherence, and outcomes from electronic health records. The award, effective August 1, 2025 through July 31, 2027, addresses a critical research challenge: amblyopia, a pediatric vision disorder...
- Summary of Federal Grant Award The National Eye Institute (NEI) awarded the University of Pittsburgh a $679,650 Project Grant under the Vision Research program (CFDA 93.867) effective June 1, 2026, through May 31, 2030. The award funds research to develop and validate adaptive optics ophthalmoscopy (AOO) as a non-invasive, label-free imaging tool for real-time assessment of immune responses in posterior uveitis, an inflammatory eye condition responsible for up to 10% of blindness in the United...
- Federal Grant Award Summary The National Eye Institute (NEI) awarded Washington University a $427,625 Project Grant under the Vision Research program (CFDA 93.867) effective April 1, 2026, through March 31, 2028, to develop novel statistical methodologies for detecting visual field (VF) progression in primary open-angle glaucoma (POAG). The project leverages the Ocular Hypertension Treatment Study (OHTS) longitudinal dataset to address critical gaps in early disease detection that currently...
- Federal Grant Award Summary The University of Alabama at Birmingham received a $636,862 Project Grant from the National Eye Institute under the Vision Research program (CFDA 93.867), effective April 1, 2026 through March 31, 2030. The research project develops and validates mechanical, vascular, and morphometric biomarkers to assess individual eye-specific susceptibility to glaucoma onset and progression. The primary deliverables include longitudinal optical coherence tomography (OCT) imaging...
- Federal Grant Award Summary The National Eye Institute (NEI) awarded The Aird $610,000 under the Vision Research program (CFDA 93.867) for a Project Grant commencing September 1, 2025, and concluding August 31, 2026. This award funds the development and commercialization of an adaptive optics optical coherence tomography (AO-OCT) system designed for high-resolution, wide-field retinal imaging in small animal models, particularly mice. The primary deliverable is a portable AO-OCT imaging system...
The University of Minnesota, through its Office of Sponsored Projects Administration, received a $764,310 Project Grant from the National Eye Institute (NEI) under the Vision Research program (CFDA 93.867), effective July 1, 2026 through December 31, 2030. The award funds development of robust, multimodal artificial intelligence (AI) models to improve prognosis and risk stratification for Primary Open-Angle Glaucoma (POAG), a leading cause of irreversible blindness affecting millions globally. The project delivers three primary products: (1) an unsupervised feature representation model that integrates multimodal clinical data—including fundus images, optical coherence tomography (OCT), visual fields (VF), and structured clinical variables—while handling missing data modalities; (2) a Multimodal Longitudinal Transformer for Survival Analysis (MLTSA) that estimates time-varying POAG risk probabilities with adaptive robustness loss to ensure consistent performance across patient populations; and (3) clinical evaluation and integration protocols developed through iterative feedback from glaucoma specialists to ensure usability and workflow alignment. These deliverables address critical gaps in current POAG risk assessment by providing automated, data-driven tools to support clinical decision-making and identify high-risk individuals for timely intervention. The research responds to documented limitations in existing predictive models, including dependence on single-modality data, poor performance across diverse patient populations, and misalignment with clinical workflows. By combining longitudinal multimodal imaging and clinical data with advanced machine learning techniques, the project aims to improve diagnostic accuracy while reducing the burden on ophthalmology specialists and enabling more efficient risk stratification in clinical settings.Federal Grant Award Summary
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | $764.3k | 6/22/26 |